Zhu Fujiang's resume

In 1975, he entered Hangzhou Minsheng Pharmaceutical Company.

In p>1983, he joined the management of Hangzhou Minsheng Pharmaceutical Company.

in p>1995, he served as the chairman and president of the company.

in p>22, he was awarded the title of the 8th Zhejiang Management Master.

in p>23, he was awarded the title of "China Management Master" by the State Council Development Research Center.

In p>24, he was rated as a model worker in Zhejiang Province.

Zhu Fujiang's favorite books are Romance of the Three Kingdoms, Water Margin and A Dream of Red Mansions.

He said that these three books condensed the three true words he admired: wisdom, righteousness and affection.

Zhu Fujiang joined the management of Hangzhou Minsheng Pharmaceutical Group Co., Ltd. in 1983 and served as the chairman and president of the company in 1995. He led all the staff of the company to seize the opportunity and blaze new trails. Today, the company's net assets exceed 5 million, ranking among the top 5 pharmaceutical industries in China, the first in chemical preparation manufacturing industry in Zhejiang Province, and the top ten pharmaceutical enterprises in Zhejiang Province. In 22, Zhu Fujiang was named as the chief entrepreneur of the US-China Economic Cooperation Organization and one of the top ten cross-century reformers in Zhejiang Province.

In p>1995, at the beginning of his tenure, Zhu Fujiang made two important decisions on enterprise marketing system and strategy: one was to recruit medical representatives nationwide and set up sales offices in large and medium-sized cities; The second is to set up a drug sales branch directly under the group. In the enterprise management system, a new system of chief engineer, chief economist and several directors who assist the general manager has been established; Under the implementation of the branch business department system, the sub-enterprises are managed in the form of wholly-owned, holding and shareholding, and the combination of capital management and product management is gradually realized. At the same time, the company's internal institutions, employment system, distribution system, personnel system and other reforms have also laid a solid foundation for the establishment of a modern enterprise system.

Zhu Fujiang, in view of China's accession to the WTO and the specific situation of intellectual property protection of patented products in various countries, on the one hand, actively introduced talents, adjusted new product development strategies and changed product development mechanisms; On the other hand, increase investment in science and technology. At present, more than 2 new varieties have been put into development, and up to now, more than 2 new drug certificates, approval numbers and clinical approvals have been obtained, and more than 2 are under declaration and preclinical research. Minsheng Group is now developing high-tech and high-value-added products based on raw materials and focusing on preparations. At present, the pharmaceutical raw materials and agents produced by the company all the year round fall into four categories, namely cardiovascular, anti-tumor, digestive tract and multi-dimensional elements.

after several years of efforts, the competitiveness and market share of the company's products have been greatly improved. At present, eight workshops (dosage forms) in Minsheng have obtained GMP certificates issued by the state, which is in a leading position in the national pharmaceutical industry. The production workshop of raw material pharmaceutical factory has passed the inspection of FDA in Hangzhou for the first time after the software and hardware transformation, and its products can directly enter the American and European markets. Through the transformation of GMP and FDA, the enterprise is in line with the international standards in terms of plant facilities, production management and product quality, which greatly enhances the international competitiveness of the enterprise.

Zhu Fujiang, through his fruitful work, Minsheng Group has successfully implemented a high starting point, unconventional and leaping development strategy. Hangzhou Minsheng Pharmaceutical Co., Ltd. has been identified as the research and production base of high-efficiency chemical raw materials and various preparations by the relevant departments of Zhejiang Province and Hangzhou Municipal Government. At present, the group company now has 8 branches and enterprises with wholly-owned, holding and shareholding, with annual sales of 8 million yuan.